IBDEI1D1 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24389,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,24390,0)
 ;;=394.9^^159^1567^9
 ;;^UTILITY(U,$J,358.3,24390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24390,1,3,0)
 ;;=3^394.9
 ;;^UTILITY(U,$J,358.3,24390,1,4,0)
 ;;=4^Mitral Valve Disease
 ;;^UTILITY(U,$J,358.3,24390,2)
 ;;=^269571
 ;;^UTILITY(U,$J,358.3,24391,0)
 ;;=443.9^^159^1567^11
 ;;^UTILITY(U,$J,358.3,24391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24391,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,24391,1,4,0)
 ;;=4^Periph Vascular Dis
 ;;^UTILITY(U,$J,358.3,24391,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,24392,0)
 ;;=424.1^^159^1567^1
 ;;^UTILITY(U,$J,358.3,24392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24392,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,24392,1,4,0)
 ;;=4^Aortic Valve Dis
 ;;^UTILITY(U,$J,358.3,24392,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,24393,0)
 ;;=459.81^^159^1567^12
 ;;^UTILITY(U,$J,358.3,24393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24393,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,24393,1,4,0)
 ;;=4^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,24393,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,24394,0)
 ;;=401.9^^159^1567^8
 ;;^UTILITY(U,$J,358.3,24394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24394,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,24394,1,4,0)
 ;;=4^Hypertension
 ;;^UTILITY(U,$J,358.3,24394,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,24395,0)
 ;;=786.50^^159^1567^6
 ;;^UTILITY(U,$J,358.3,24395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24395,1,3,0)
 ;;=3^786.50
 ;;^UTILITY(U,$J,358.3,24395,1,4,0)
 ;;=4^Chest Pain
 ;;^UTILITY(U,$J,358.3,24395,2)
 ;;=^22485
 ;;^UTILITY(U,$J,358.3,24396,0)
 ;;=412.^^159^1567^10
 ;;^UTILITY(U,$J,358.3,24396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24396,1,3,0)
 ;;=3^412.
 ;;^UTILITY(U,$J,358.3,24396,1,4,0)
 ;;=4^Old Myocardial Infarct
 ;;^UTILITY(U,$J,358.3,24396,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,24397,0)
 ;;=414.00^^159^1567^3
 ;;^UTILITY(U,$J,358.3,24397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24397,1,3,0)
 ;;=3^414.00
 ;;^UTILITY(U,$J,358.3,24397,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,24397,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,24398,0)
 ;;=414.01^^159^1567^4
 ;;^UTILITY(U,$J,358.3,24398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24398,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,24398,1,4,0)
 ;;=4^CAD of Native Artery
 ;;^UTILITY(U,$J,358.3,24398,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,24399,0)
 ;;=285.9^^159^1568^1
 ;;^UTILITY(U,$J,358.3,24399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24399,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,24399,1,4,0)
 ;;=4^Anemia
 ;;^UTILITY(U,$J,358.3,24399,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,24400,0)
 ;;=266.2^^159^1568^3
 ;;^UTILITY(U,$J,358.3,24400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24400,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,24400,1,4,0)
 ;;=4^B12 & Folate Anemia
 ;;^UTILITY(U,$J,358.3,24400,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,24401,0)
 ;;=250.00^^159^1568^7
 ;;^UTILITY(U,$J,358.3,24401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24401,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,24401,1,4,0)
 ;;=4^DM type II,not uncontrolled
 ;;^UTILITY(U,$J,358.3,24401,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,24402,0)
 ;;=272.4^^159^1568^12
 ;;^UTILITY(U,$J,358.3,24402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24402,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,24402,1,4,0)
 ;;=4^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,24402,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,24403,0)
 ;;=244.9^^159^1568^13
 ;;^UTILITY(U,$J,358.3,24403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24403,1,3,0)
 ;;=3^244.9
 ;;^UTILITY(U,$J,358.3,24403,1,4,0)
 ;;=4^Hypothyroidism
